Medetomidine is replacing xylazine in Philly street fentanyl − creating new hurdles for health care providers and drug users
Medetomidine is used in veterinary medicine, often during surgery. It's becoming common in the city's drug supplies, and it ...
EU regulator declines approval for Eli Lilly’s new Alzheimer’s drug
The EU’s medicines regulator has declined to approve Eli Lilly’s new Alzheimer’s drug, deciding the risks of serious and potentially fatal side effects outweigh the benefits of slowing progression of ...
Everyday Health on MSN16h
New UTI Antibiotic Is the First Approved by the FDA in Nearly 30 Years
This antibiotic is the first new FDA-approved medication for urinary tract infections in decades, and meets the need for new ...
IASO Bio Announces Approval of New Drug Application for Equecabtagene Autoleucel by the Macau Pharmaceutical Administration Bureau
IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative cell therapies and biologics, today announced ...
Liquidia Corporation Announces FDA Acceptance of New Drug Application Resubmission for YUTREPIAâ„¢ (treprostinil) Inhalation Powder
FDA sets PDUFA goal date of May 24, 2025MORRISVILLE, N.C., March 28, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for ...
MPR2h
New Formulation of Tesamorelin Approved for HIV-Related Lipodystrophy
The F8 formulation is 8 times more concentrated than Egrifta and 2 times more concentrated than the current F4 formulation, Egrifta SV.
Healio20h
FDA recap: First new treatment for stroke in 3 decades, generic rivaroxaban and more
The FDA recently approved the first treatment in nearly 30 years for acute stroke, and the agency also approved a novel drug ...
EU regulators block new Alzheimer’s drug citing potentially fatal side effects
The company behind the drug donanemab said it will ask regulators to reconsider the decision. View on euronews ...
Novo Nordisk to license obesity drug from Lexicon in up to $1 billion deal
Novo Nordisk is licensing Lexicon Pharmaceuticals' experimental obesity drug in a deal worth up to $1 billion, the Danish ...
McKnight's Long-Term Care News12h
FDA approves gepotidacin antibiotic for uncomplicated urinary tract infections
The Food and Drug Administration has approved a new antibiotic that can treat uncomplicated urinary tract infections, or ...
Debate over the abortion pill mifepristone resurfaces after Makary confirmed to head the FDA
The FDA-approved abortion pill mifepristone is under scrutiny as the new Republican administration takes charge ...
Medscape1h
Pirtobrutinib’s Star Turn in Relapsed/Refractory CLL May Get an Encore
In just over a year since its US Food and Drug Administration (FDA) approval, pirtobrutinib (Jayprica) has become a standard ...